NanoRepro AG
XETRA:NN6
NanoRepro AG
XETRA:NN6
Price:
1.83 EUR
-0.27%
Market Closed
Updated:
May 1, 2024
NanoRepro AG
Operating Income
|
NanoRepro AG
Operating Income Peer Comparison
Comparables:
AFX
EUZ
SHL
DRW8
SRT
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NanoRepro AG
XETRA:NN6
|
Operating Income
€38.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Operating Income
€331.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Operating Income
€44.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Operating Income
€2.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Operating Income
€186.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-1%
|
|
|
Sartorius AG
XETRA:SRT
|
Operating Income
€447.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
15%
|
See Also
What is NanoRepro AG's Operating Income?
Operating Income
38.8m
EUR
38.8m
EUR
Based on the financial report for Dec 31, 2021, NanoRepro AG's Operating Income amounts to 38.8m EUR.
What is NanoRepro AG's Operating Income growth rate?
Operating Income CAGR 1Y
734%
734%
Over the last year, the Operating Income growth was 734%.
You don't have any saved screeners yet
